Stock Yearly Return 2013
Start date: 12/31/2012
End date: 12/31/2013
Start price/share: $28.50
End price/share: $4.50
Dividends collected/share: $0.00
Total return: -84.21%
Average Annual Total Return: -84.21%
Starting investment: $10,000.00
Ending investment: $1,579.00
Years: 1.00


DFFN average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare DFFN average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into DFFN


Also see:
DFFN stock yearly return 2014
DFFN stock yearly return 2015
DFFN stock yearly return 2016
DFFN stock yearly return 2017
DFFN stock yearly return 2018
DFFN stock yearly return 2019
DFFN stock yearly return 2020
DFFN YTD return
DFFN average annual return 10 years
Diffusion Pharmaceuticals is a clinical stage biotechnology company. Co. is developing its primary product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC). TSC is designed to selectively target and re-oxygenate the micro-environment of hypoxic cells, and can potentially be used in various indications, including stroke, oncology and cardiovascular disease. Co.'s oncology program targets TSC against treatment-resistant brain cancer. In addition to the TSC programs, Co. is exploring alternatives to capitalize upon its product candidate RES-529, a PI3K/Akt/mTOR pathway inhibitor for age-related macular degeneration. The DFFN stock yearly return is shown above.

The yearly return on the DFFN stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2013 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the DFFN annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for DFFN:
DFFN SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Diffusion Pharmaceuticals (DFFN) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

DGX Average Annual Return
DHR Average Annual Return
DMPI Average Annual Return
DOVA Average Annual Return
DPLO Average Annual Return
DRAD Average Annual Return
DRIO Average Annual Return
DRNA Average Annual Return
DRRX Average Annual Return
DVA Average Annual Return
More Healthcare companies »

 

DFFN Stock Yearly Return 2013 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.